Spruce Biosciences, Inc. · NASDAQ:SPRB
Carlyle Group Inc. reported a 4.70% stake in Spruce Biosciences, Inc. (Schedule 13D/A)
Event Feb 18, 2026 · Filed Feb 18, 2026
Carlyle Group Inc. reported a 4.70% stake in Spruce Biosciences, Inc., 50,893 shares, with active intent on Feb 18, 2026. Filed Feb 18, 2026 (Schedule 13D/A).
- Stake
- 4.70%
- Shares
- 50,893
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Carlyle Group Inc. | 4.70% | 50,893 |
| Carlyle Holdings I GP Inc. | 4.70% | 50,893 |
| Carlyle Holdings I GP Sub L.L.C. | 4.70% | 50,893 |
| Carlyle Holdings I L.P. | 4.70% | 50,893 |
| CG Subsidiary Holdings L.L.C. | 4.70% | 50,893 |
| TC Group, L.L.C. | 4.70% | 50,893 |
| Carlyle Investment Management L.L.C. | 4.70% | 50,893 |
| Carlyle Genesis UK LLC | 4.70% | 50,893 |
| Abingworth LLP | 4.70% | 50,893 |
| Abingworth Bioventures VII LP | 4.70% | 50,893 |
Source
Related
- Spruce Biosciences, Inc.
- Carlyle Group Inc.
- Spruce Biosciences, Inc. shareholders
- Schedule 13G · AWM Investment Company, Inc. · Aug 14, 2026
- Schedule 13G/A · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G · Orbimed Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Citadel Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Millennium Management LLC · Aug 4, 2026